Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Clinical Trials: Chronic Myeloid Leukemia
A listing of clinical trials currently looking for volunteers to enroll in Chronic Myeloid Leukemia studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Muscle Shoals : Northwest Alabama Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Arizona
Sedona : Arizona Oncology Associates, PC - NAHOA
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Arkansas
Hot Springs National Park : Genesis Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Jonesboro : NEA Baptist Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Little Rock : Little Rock Hematology Oncology Associates
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
California
Duarte : City of Hope Updated
A Phase I Dose Escalation Study of LBH589 in Combination with Imatinib Mesylate for Patients with Chronic Myeloid Leukemia in Cytogenetic Remission with Residual Disease Detectable by Q-PCR
Duarte : City of Hope
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults with Hematologic Malignancy
Duarte : City of Hope Updated New
Comparative Evaluation of the Cepheid Xpert BCR-ABL Monitor Assays
Duarte : City of Hope Updated
Immune Studies in Chronic Myelogenous Leukemia (CML)
Duarte : City of Hope
SWOG 9007: Cytogenetic Studies In Leukemia Patients
View More »
Anaheim : Pacific Cancer Medical Center, Inc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Escondido : Southwest Cancer Care Medical Group
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Glendora : Wilshire Oncology Medical Group, Inc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
La Jolla : University of San Diego Medical Center Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Los Angeles : University of Southern California
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Oxnard : PMK Medical Group, Inc. DBA Ventura
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
San Francisco : University of California Medical Center Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Stanford : Stanford University Medical Center Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Colorado
Boulder : Rocky Mountain Cancer Centers
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Connecticut
Manchester : Medical Oncology and Blood Disorders, LLP
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Florida
Boynton Beach : Hematology And Medical Oncology Of Southern Palm Beach County
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Hialeah : Palm Springs Research Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Jacksonville : Baptist Cancer Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Port Richey : Florida Cancer Specialists
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Orlando : Cancer Centers of Florida
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
View More »
Tavares : Lake County Oncology and Hematology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Titusville : Space Coast Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Georgia
Atlanta : Emory University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Marietta : Northwest Georgia Oncology Centers, PC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Sandy Springs : Georgia Cancer Specialist
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Hawaii
Honolulu : Straub Clinical & Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Illinois
Chicago : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Evergreen Park : Mahafzah Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Niles : Orchard Health Care Research
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
North Chicago : North Chicago VA Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Indiana
Anderson : Saint John's Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Beech Grove : Indiana Blood and Marrow Transplantation, LLC Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Beech Grove : Indiana Blood and Marrow Transplantation
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Albany : Cancer Care Center, Inc. PC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Iowa
Mason City : N. Iowa Mercy Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Kansas
Hutchinson : Hutchinson Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Topeka : Cotton O'Neil Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wichita : Cancer Center of Kansas
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Kentucky
Lexington : Central Baptist Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Louisiana
Shreveport : Willis-Knighton Cancer System
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Maryland
Columbia : Maryland Oncology Hematology Pa
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Massachusetts
Concord : Commonwealth Hematology-Oncology, P.C.
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Worcester : University of Massachusetts Memorial Medical Center Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Michigan
Kalamazoo : West Michigan Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Minnesota
Minneapolis : University of Minnesota Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Missouri
Springfield : St John's Clinic for Cancer and Hematology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Montana
Billings : Billings Clinic
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Hampshire
Portsmouth : Portsmouth Regional Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New Jersey
Hackensack : Hackensack University Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Morristown : Hematology-Oncology Associates of Northern NJ, PA
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Vineland : Southern Oncology Hematology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New York
Johnson City : Broome Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
New York : Advanced Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Stony Brook : Stony Brook University Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
North Carolina
Cary : Waverly Hematology Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Durham : Duke University Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Gastonia : Gaston Hematology Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Greenville : East Carolina University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Ohio
Akron : Akron General Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Cleveland : Cleveland Clinic Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Cleveland : University Hospitals Case Medical Center Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Middletown : Signal Point Clinical Research Center, LLC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Newark : Medical Center of Newark
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Oklahoma
Tulsa : Cancer Care Associates
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Oregon
Portland : Oregon Health & Science University
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Pennsylvania
Kingston : Medical Oncology Associates of Wyoming Valley, PC
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lancaster : Lancaster General Health
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Norristown : Luitpold Pharmaceuticals, Inc.
Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia
Pittsburgh : The Western Pennsylvania Hospital Updated
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia
Pittsburgh : Veterans Research Foundation of Pittsburgh
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
View More »
Wilkes Barre : Geisinger Health System
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Rhode Island
Cranston : Hematology and Oncology Associates of RI
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
South Dakota
Watertown : Prairie Lakes Healthcare System, Inc
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Tennessee
Knoxville : Tennessee Cancer Specialists
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Memphis : St. Jude Children's Research Hospital Updated
A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
Texas
Amarillo : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Arlington : Texas Oncology - Arlington South
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Austin : Texas Oncology-Austin North
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Beaumont : Julie & Ben Rogers Cancer Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Dallas : Texas Oncology-Dallas Presbyterian Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
View More »
Dallas : Texas Oncology-Medical City Dallas
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Dallas : Texas Oncology-Methodist Charlton Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Houston : Michael DeBakey VA Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Lewisville : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
McAllen : Texas Oncology-McAllen South Second
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Mesquite : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Midland : Texas Oncology-Midland Allison Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Odessa : Texas Oncology-Odessa West Texas Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Paris : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Plano : North Texas Regional Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
San Antonio : Cancer Care Centers of South Texas
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Waco : Texas Oncology
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Virginia
Fredericksburg : Hematology Oncology Associates of Fredricksburg
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Newport News : Peninsula Cancer Institute
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Roanoke : Blue Ridge Cancer Care
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Washington
Spokane : Providence Cancer Center at Sacred Heart Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wenatchee : Wenatchee Valley Medical Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
West Virginia
Martinsburg : City Hospital - West Virginia University Hospital East
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wheeling : Wheeling Hospital
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Wisconsin
Wausau : Aspirus Regional Cancer Center
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Argentina
Buenos Aires : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Parana, Entre Rios : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Australia
Adelaide : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Canada
Toronto : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Vancouver : Leukemia BMT program of BC, Vancouver General Hospital, Hematology Research and Clinical Trials Unit
A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib
China
Beijing : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
Chengdu : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
Fuzhou : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
Guangzhou : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
Hangzhou : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
View More »
Jinan : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
Nan Jing : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
Shanghai : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
Tianjin : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
Wuhan : Novartis Investigative Site
Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients
France
Bordeaux : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Lille cedex : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Paris : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Paris Cedex 19 : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Poitiers : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
View More »
Poitiers : University Hospital
Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation
Poitiers : University Hospital
STI571 ProspectIve RandomIzed Trial: SPIRIT
Germany
Aschaffenburg : Local Institution
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Baden-Baden : Local Institution
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Berlin : Novartis Investigative Site
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib
Frankfurt am Main : Local Institution
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Frankfurt/M : Novartis Investigative Site
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib
View More »
Jena : Novartis Investigative Site
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib
Leipzig : Novartis Investigative Site
Determining the Maximum Tolerated Dose of Low Dose Interferon-alfa in Conjunction With Nilotinib in Imatinib Resistant and/or Intolerant Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)
Mannheim : Novartis Investigative Site
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib
Offenbach : Local Institution
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Ulm : Novartis Investigative Site
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib
Israel
Ramat Gan : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Ramat Hadassah : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Italy
Monza : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Padova : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Roma : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Japan
Nagoya :
Phase I Study of OPB-51602 in Patients With Hematologic Malignancies
Tokyo :
Phase I Study of OPB-51602 in Patients With Hematologic Malignancies
Korea, Republic of
Seoul : Seoul St. Mary's Hospital
Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib
Lebanon
Saida : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Malaysia
Penang : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Mexico
San Luis Potosi : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Sonora : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Netherlands
Rotterdam : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Puerto Rico
Bayamon : Puerto Rico Hematology Oncology Group
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Taiwan
Kaohsiung : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Kaohsiung County : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Taipei City : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Taoyuan County : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Thailand
Chiang Mai : Novartis Investigative Site
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Khon Kaen : Novartis Investigative SiteKhon Kaen
Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
United Kingdom
Birmingham : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Bristol : Novartis Investigative Site
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Glasgow : Novartis Investigative Site
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib
